Research Awards

As the largest non-governmental funder of inflammatory bowel disease (IBD) research in Canada, Crohn’s and Colitis Canada proudly celebrates and recognizes Canadian IBD researchers for their exceptional contributions to the field of IBD research through four awards. 

The notable awards, which you can learn more about below, include:

  • Research Leadership Award
  • Rising Star Award
  • Women in IBD: Outstanding Researcher Award
  • Women in IBD: Emerging Researcher Award

From seasoned investigators to emerging researchers, the recipients of these awards drive essential research that advances our promise to discover cures and improve quality of life for people affected by Crohn’s disease or ulcerative colitis.

We encourage you to nominate your IBD colleagues for these research awards to recognize their contributions to the Canadian IBD research landscape. We also accept self-nominations for the Women in IBD Awards.

Please note that each award has its own eligibility, nomination, and selection criteria. To submit a nomination, you must complete an online application form and provide other required materials by the stipulated due date. 

Research Leadership Award

The Research Leadership Award recognizes an individual who demonstrates leadership in the field of IBD research, significantly contributes to advancing Crohn’s and colitis research in Canada, and makes exceptional contributions to Crohn’s and Colitis Canada’s mission and promise.

The nominations are now closed.

To learn more about the Research Leadership Award or submit a nomination, click here

Rising Star Award

The Rising Star Award recognizes the basic or clinical research accomplishments of an outstanding emerging investigator, within five years of their first faculty appointment (the five year period criterion will be extended for individuals who have taken extended leaves of absence due to life circumstances, such as parental or sick leave). The recipient is an innovative leader who advances Crohn's and colitis research in Canada, and has made an outstanding contribution to Crohn’s and Colitis Canada’s mission.

The nominations are now closed.

To learn more about the Rising Star Award or submit a nomination, click here

WOMEN in  IBD Awards: Outstanding Researcher Award and Emerging Researcher Award

Crohn’s and Colitis Canada and Pfizer Canada’s Women in IBD Awards provide research program funding to recognize women of influence who are making outstanding contributions to the field of IBD research. Recipients will have their travel, accommodations and conference fees paid to attend the Meeting of the Minds conference and present their work. Nominations will be reviewed and selected based on the nominee’s impact on the Canadian IBD community, contributions to Crohn’s and Colitis Canadas mission, and demonstration of innovation and leadership in the field of IBD research. 

Women in IBD: Outstanding Researcher Award

This award recognizes an exceptional female IBD basic or clinical researcher who has been an inspirational leader and role model in the field of IBD research, and contributed significantly to advancing Crohn’s and Colitis Canada’s mission. The recipient will receive $25,000 to support their IBD research program. 

The nominations are now closed.

To learn more about the Outstanding Researcher Award or submit a nomination, click here

Women in iBD: Emerging Researcher Award

This award acknowledges the basic or clinical research accomplishments of a junior/newly emerging female IBD researcher, within 5 years of their first faculty appointment (not including any leaves of absence), who has shown creativity, initiative and commitment to advancing IBD research and quality of patient care in Canada. The recipient will receive $15,000 to support their IBD research program. 

The nominations are now closed.

To learn more about the Emerging Researcher Award or submit a nomination, click here

 

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest